Intas Pharmaceuticals has launched RAZUMAB, its biosimilar to Lucentis (ranibizumab).
Retina India is a not-for-profit organization, registered with the Charity Commissioner, Mumbai, India, established for empowering people with retinal disorders, and bringing them and their families on a common platform with physicians, researchers, counselors, low vision and mobility experts and other specialists.
Showing posts with label intravitreal injections. Show all posts
Showing posts with label intravitreal injections. Show all posts
Tuesday, June 23, 2015
Thursday, April 23, 2015
Scleral thinning seen following intravitreal anti-VEGF injections
Research conducted at the University Hospital in Bern, Switzerland suggests that scleral changes may occur in patients following repeated intravitreal injections of anti-VEGF agents in the same quadrant.
Subscribe to:
Posts (Atom)